ADPT

Adaptive Biotechnologies Corporation Common Stock

27.89

USD

-0.17

-0.61%

Sep 23, 15:59 UTC -4

Closed

After-Market

28.33

+0.44

+1.58%

Adaptive Biotechnologies Corporation Common Stock Profile

About

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.

Info & Links

CEO

Chad Robins

Headquarters

1165 EASTLAKE AVENUE EAST, SUITE 200
SEATTLE, WA 98109, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

624

Adaptive Biotechnologies Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

4.52B

Enterprise Value

4.69B

Enterprise Value/EBITDA(ttm)

-209.42

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

14.43

Price to Book(mrq)

29.59

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.17%

Operating Margin(ttm)

-24.02%

Profit Margin(ttm)

-23.16%

Return on Equity(ttm)

-36.81%

Return on Invested Capital(ttm)

-18.51%

Return on Assets(ttm)

-13.77%

Income Statement

Revenue(ttm)

308.08M

Revenue Per Share(ttm)

1.93

Gross Profit(ttm)

232.83M

EBITDA(ttm)³

-22.38M

Net Income Available to Common(ttm)

-63.85M

Diluted EPS(ttm)

-0.41

Share Statistics

Beta (5Y Monthly)

2.09

52-Week Change

100.07%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

159.60M

Dividend Yield

0.00%

Float⁴

150.50M

% Held by Insiders

5.70%

% Held by Institutions

99.17%

Balance Sheet

Total Cash(mrq)

344.25M

Total Cash Per Share(mrq)

2.16

Total Debt(mrq)

334.88M

Total Debt/Equity(mrq)

222.27%

Current Ratio(mrq)

4.79%

Quick Ratio(mrq)

4.68%

Book Value Per Share(mrq)

0.95

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.10

Free Cash Flow(ytd)

-17.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.